Capital Bank & Trust’s GSK GSK Stock Holding History

Capital Bank & Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,665	Closed	-$208K	–	271
2021 Q1	$208K	Sell	4,665 -1,198	-20%	-$54.4K	﹤0.01%	352
2020 Q4	$270K	Sell	5,863 -219,114	-97%	-$10.1M	﹤0.01%	309
2020 Q3	$10.6M	Buy	224,977 +3,882	+2%	+$195K	0.14%	110
2020 Q2	$11.3M	Buy	221,095 +71,269	+48%	+$3.66M	0.16%	107
2020 Q1	$7.1M	Buy	149,826 +145,431	+3,309%	+$7.76M	0.12%	119
2019 Q4	$258K	Hold	4,395	–	–	﹤0.01%	272
2019 Q3	$234K	Hold	4,395	–	–	﹤0.01%	275
2019 Q2	$220K	Hold	4,395	–	–	﹤0.01%	282
2019 Q1	$230K	Hold	4,395	–	–	﹤0.01%	266
2018 Q4	$210K	Hold	4,395	–	–	﹤0.01%	282
2018 Q3	$221K	Hold	4,395	–	–	﹤0.01%	279
2018 Q2	$221K	Hold	4,395	–	–	﹤0.01%	275
2018 Q1	$215K	Hold	4,395	–	–	﹤0.01%	256
2017 Q4	$195K	Hold	4,395	–	–	﹤0.01%	277
2017 Q3	$223K	Hold	4,395	–	–	﹤0.01%	248
2017 Q2	$237K	Buy	+4,395	New	+$234K	﹤0.01%	236

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Capital Bank & Trust's GSK Position: Q2 2021 in Review

Capital Bank & Trust sold out of GSK (GSK) in Q2 2021, closing a stake of 4,665 shares — an estimated $208K sold.

Capital Bank & Trust first reported a position in GSK in Q2 2017 and held it in 16 quarters. The position peaked at $11.3M in Q2 2020. 798 funds tracked by Wall St. Rank hold GSK as of Q2 2021.

Capital Bank & Trust reported no remaining GSK position as of Q2 2021 after selling out during the quarter.
Capital Bank & Trust sold 4,665 GSK shares in Q2 2021, an estimated $208K.
Capital Bank & Trust first reported a position in GSK in Q2 2017 and held it in 16 quarters.
Capital Bank & Trust's GSK position peaked at $11.3M in Q2 2020.
798 funds tracked by Wall St. Rank held GSK as of Q2 2021.

Based on Capital Bank & Trust's 13F filing for Q2 2021, filed 16 Aug 2021.